#biotech — FinScans

Release 📈 Stocks

REGENXBIO Schedules Investor Event Ahead of 4Q 2026 Sura-vec Data Readout

October 12, 2026 (29 days ago)

REGENXBIO sets investor event to discuss the sura-vec wet AMD program, providing clinical updates and specialist perspectives ahead of the anticipated 4Q…

RGNX

🌍 AMERICAS Read More →

Release 📈 Stocks

Yelloway Develops Disease-Resistant Banana to Secure Future Supply

October 9, 2026 (32 days ago)

Yelloway announces a breakthrough in banana breeding, creating a disease-resistant fruit that preserves traditional flavor and commercial scalability to combat global agricultural…

Chiquita Yelloway

🌍 AMERICAS Read More →

Release 📈 Stocks

Eli Lilly Shares Gain as TOGETHER-PsO Data Shows Zepbound Efficacy

October 9, 2026 (32 days ago)

Eli Lilly's latest clinical data reveals that the combination of Taltz and Zepbound drives significant biomarker improvements in psoriasis patients, reinforcing the…

LLY

🌍 AMERICAS Read More →

Release 📈 Stocks

MOYOM Biotech Brand Aphranel Sponsors 2026 MXGP Shanghai Event

October 9, 2026 (32 days ago)

MOYOM Biotech's aphranel brand gains visibility through a strategic partnership with the 2026 MXGP Shanghai, marking a push into sports-integrated marketing for…

MOYOM Biotech

🌍 ASIA Read More →

News 📈 Stocks

Anavex Life Sciences Shares Slip as Board Admits Incomplete Data Disclosures

October 8, 2026 (33 days ago)

Anavex Life Sciences faces potential volatility as the company warns investors to rely only on updated clinical trial data following admissions of…

AVXL

🌍 AMERICAS Read More →

Release 📈 Stocks — 📊 Neutral

Aardvark Therapeutics Appoints David Zhang to Board of Directors

October 8, 2026 (33 days ago)

Aardvark Therapeutics strengthens its board of directors with the addition of industry veteran David Zhang, leveraging his extensive background in clinical development…

🌍 AMERICAS Read More →

Release 📈 Stocks

Victory Square Technologies Gains U.S. Patent Allowance for Insu Therapeutics

October 8, 2026 (33 days ago)

Victory Square Technologies secures a key U.S. patent for Insu Therapeutics, enhancing the commercial potential of its InsuTab and BuccaGLP platforms while…

Insu Therapeutics VST NURS

🌍 AMERICAS Read More →

Release 📈 Stocks

Veeva Systems Showcases AI Innovations at R&D and Quality Summit

October 8, 2026 (33 days ago)

Veeva Systems convenes global pharmaceutical leaders in Boston to demonstrate AI-powered software designed to streamline drug development, clinical trials, and quality manufacturing…

VEEV LLY PFE +2

🌍 AMERICAS Read More →

Release 📈 Stocks

Draper Secures $7.3 Million ARPA-H Grant for BioStabilization Research

October 7, 2026 (34 days ago)

Draper Laboratory lands a $7.3 million ARPA-H contract to spearhead Phase 1 of the BioStabilization Systems program, marking a significant win for…

Draper Laboratory

🌍 AMERICAS Read More →

Release 📈 Stocks — 📈 Bullish

Celltaxis Shares Rally as Clinical Data Validates LTA4H Inhibitor Efficacy

October 7, 2026 (34 days ago)

Positive clinical findings published in Scientific Reports provide independent validation for Celltaxis' therapeutic approach, driving short-term investor optimism regarding its LTA4H inhibitor…

🌍 GLOBAL Read More →

Filing 📈 Stocks

Caribou Biosciences Discloses Restructuring Costs and Executive Departures

October 6, 2026 (34 days ago)

Caribou Biosciences faces short-term headwinds as it reports restructuring costs and leadership changes in a recent 8-K filing, impacting investor sentiment.

CRBU

🌍 AMERICAS Read More →

Release 📈 Stocks

Luminous Mind Secures Patent for Non-Hallucinogenic Psychedelic Compounds

October 6, 2026 (35 days ago)

Luminous Mind, Inc. targets a billion-dollar market opportunity after securing a U.S. patent for non-hallucinogenic psychedelic compounds, sparking interest in potential strategic…

LMI

🌍 AMERICAS Read More →